Poland· PL-100226623
Pangrol 25 000
A multienzyme - lipase, protease etc product containing pancreatinum, registered in Poland by Berlin-Chemie AG. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Multienzyme - lipase, protease etc is registered in 11 of 19 countries.
Countries holding a registration under ATC A09AA02 (multienzyme - lipase, protease etc), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Multienzyme - lipase, protease etc · ATC A09AA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Pancreatinum
- Manufacturer
- Berlin-Chemie AG
- Country
- Poland (PL)
- ATC code
- A09AA02
- ATC class
- Multienzyme - Lipase, Protease etc
- Defined daily dose
- 240 TSD, FIP
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990943517
- gtin05909990943524
- gtin05909991561413
- gtin05909991561420
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for multienzyme - lipase, protease etc.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Multienzyme - lipase, protease etc · interactions on record
20 records
- 20 moderate
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Calcium carbonateA02AC01moderate
- MagaldrateA02AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Multienzyme - lipase, protease etc in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKREONVIATRIS HEALTHCARE LIMITED, Dublin
- FinlandCreon 10 000Oy Cross Pharma Ab
- IrelandCreon 10000 Gastro-resistant CapsulesViatris Healthcare Limited
- SwitzerlandCreon 10000
- GermanyKreonViatris Healthcare Gmbh
- NorwayCreon 10000Viatris AS
- FranceEUROBIOL 12 500 U, gélule gastrorésistanteLABORATOIRES MAYOLY SPINDLER
- BelgiumEnzepi 10000 UAptalis Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Kreon, Kreon – Kapseln
- Belgium · Ankreta, Creon
- Bulgaria · Креон
- Cyprus · Creon
- Czechia · Kreon, Pancreolan Forte 6000
- Germany · Kreon, Pancrin
- Denmark · Creon
- Estonia · Kreon, Mezym
- Spain · Kreon
- Finland · Creon, Micrazym
- France · Creon
- United Kingdom (Northern Ireland) · Creon, Creon Micro
- Greece · Creon, Creon-P
- Croatia · Kreon, Pangrol
- Hungary · Dipankrin Optimum, Kreon
- Ireland · Creon, Creon For Children
- Iceland · Creon
- Italy · Creon, Creonipe
- Lithuania · Kreon, Pangrol
- Luxembourg · Ankreta, Creon
- Latvia · Kreon, Pangrol
- Malta · Creon
- Netherlands · Creon, Micrazym
- Norway · Creon
- Portugal · Kreon, Kreon 25000
- Romania · Kreon, Mezym
- Sweden · Creon, Micrazym
- Slovenia · Kreon, Kreon Epi
- Slovakia · Kreon, Pancreolan Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d542fcdb-6472-4476-b8de-a64a3c54b484 GET /v1/drugs/d542fcdb-6472-4476-b8de-a64a3c54b484?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki",
"source": "urpl",
"strength": "25 000 j.Ph.Eur. lipazy",
"packaging": "05909990943517 ¦ OTC ¦ 19387\n20 kaps. w butelce\n05909990943524 ¦ OTC ¦ 19389\n50 kaps. w butelce\n05909991561413 ¦ OTC ¦ 159461\n20 kaps. w blistrze\n05909991561420 ¦ OTC ¦ 159462\n50 kaps. w blistrze",
"substance": "Pancreatinum (lipazy 10 000 j. Ph.Eur., amylaza 9 000 j. Ph.Eur., proteazy 500 j. Ph.Eur) 356,1 mg/kapsułkę",
"common_name": "Pancreatinum",
"pl_product_id": "100226623",
"pozwolenie_nr": "09435",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about multienzyme - lipase, protease etc.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.